Related Experiment Videos
Thalassemias and their dental implications
Antonio Cutando Soriano1, José Antonio Gil Montoya, Juan de Dios López-González Garrido
1Facultad de Odontologia. Universidad de Granada. Spain. acutando@ugr.es
Medicina Oral : Organo Oficial De La Sociedad Espanola De Medicina Oral Y De La Academia Iberoamericana De Patologia Y Medicina Bucal
|January 15, 2002
Summary
Beta-thalassemia patients require specialized dental care due to anemia complications. Advances in treatment, including transfusions and potential gene therapy, improve long-term oral health outcomes.
Area of Science:
- Hematology
- Oral Medicine
- Genetics
Background:
- Thalassemias are inherited blood disorders causing anemia.
- Severe beta-thalassemia presents significant challenges for dental treatment planning.
- Orofacial manifestations, like malocclusion, result from bone marrow expansion.
Purpose of the Study:
- To highlight the dental management considerations for patients with severe beta-thalassemia.
- To discuss current and future therapeutic strategies impacting dental care.
- To emphasize the need for integrated dental and medical treatment.
Main Methods:
- Review of current medical and dental literature on thalassemia.
- Analysis of clinical manifestations and treatment adaptations.
- Discussion of emerging therapies like gene therapy.
Main Results:
- Improved medical treatments allow more thalassemia patients to reach adulthood.
- Early medical intervention reduces the severity of orofacial complications.
- Oral chelators and fetal hemoglobin inducers are key therapeutic targets.
Conclusions:
- Dental professionals must adapt treatments for thalassemia patients.
- Ongoing research aims for more effective and affordable therapies.
- Gene therapy holds promise for complete patient healing and normal facial structure.